IL4I1 and neoplasm: The results indicated that five of seven methylated CpGs of IL4I1 (cg06388099, cg05934682, cg03166835, cg24160312, and cg10805880) exhibited significant reductions with increasing tumor grade, and were lower in WHO III compared with WHO II (Supplementary Figure S3A).